Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos E Milla

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
SAR-444245, an engineered not-alpha IL-2 leveraging synthetic biology, modulates critical components of the immune system for durable anti-tumoral activityLina Ma, Nicole V Acuff, Jerod L Ptacin, et al.
Communications Medicine|March 27, 2024
A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organismJerod L Ptacin, Lina Ma, Carolina E Caffaro, et al.
Cancer Research Communications|September 25, 2024
A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman PrimatesLina Ma, Nicole V Acuff, Ingrid B Joseph, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiationPejman Soroosh, Jiejun Wu, Xiaohua Xue, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded LibraryMarcos E Milla, Jonathan M Blevitt, Steven D Goldberg, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
SAR-444245, an engineered not-alpha IL-2 leveraging synthetic biology, modulates critical components of the immune system for durable anti-tumoral activityLina Ma, Nicole V Acuff, Jerod L Ptacin, et al.
Communications Medicine|March 27, 2024
A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organismJerod L Ptacin, Lina Ma, Carolina E Caffaro, et al.
Cancer Research Communications|September 25, 2024
A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman PrimatesLina Ma, Nicole V Acuff, Ingrid B Joseph, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2014
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiationPejman Soroosh, Jiejun Wu, Xiaohua Xue, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded LibraryMarcos E Milla, Jonathan M Blevitt, Steven D Goldberg, et al.
Pageof 4